EUVIMEDEUVIMED entdecken
Open Access

Rewiring STAT signaling from the cell surface with Trikine immunotherapeutics

Grayson E Rodriguez iD, Yang Zhao iD, Yoko Nishiga, Frank Peprah iD, Jiao Shen iD, Gita C Abhiraman iD, Masato Ogishi iD, Chenyu Zhang iD, Justin Saco iD, Deepa Waghray, Mamatha Serasanambati iD, Leonel Torres und 25 weitere

Science · 14.05.2026 · 392 (6799)

DOI: 10.1126/science.adx9954 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, erschienen am 14.05.2026. Verfasst von Grayson E Rodriguez und 36 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Program, Stanford University, Stanford, CA, USA. Hauptthemen laut MEDLINE: Cytokines, Immunotherapy, Interleukin-10, Interleukin-2. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIAID NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cytokines dimerize two receptor chains to activate Janus kinases and signal transducer and activator of transcription (STAT) transcription factors that regulate immune cells, but they have therapeutic liabilities. We engineered “Trikines” to compel cis formation of three-chain cytokine receptor complexes at the cell surface that induce bespoke STAT transcriptional signaling programs. Trikines coactivated phosphorylation of STAT5 (pSTAT5) and pSTAT3 signatures distinct from natural cytokines by assembling trimeric combinations of interleukin-2 (IL-2), IL-10, and IL-21 receptors. In preclinical models, an IL-2–based Trikine restrained terminal differentiation of T cells, promoted stemness, and enhanced durability of tumor control without observable toxicity. An IL-10–based Trikine induced immune infiltration into poorly immunogenic tumors, showing efficacy in preclinical models of small cell lung cancer and pancreatic cancer. Trikines obviate the need for cell engineering to customize STAT signatures and may hold potential for immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CytokinesImmunotherapyInterleukin-10Interleukin-2Signal TransductionSTAT3 Transcription FactorSTAT5 Transcription FactorAnimalsHumansMiceCell DifferentiationCell Line, TumorLung NeoplasmsPhosphorylationProtein MultimerizationReceptors, InterleukinT-LymphocytesProtein Engineering

Substanzen

CytokinesInterleukin-10Interleukin-2Receptors, InterleukinSTAT3 Transcription FactorSTAT5 Transcription Factor

Autor:innen und Institutionen

  • Immunology Program, Stanford University, Stanford, CA, USA.
  • Department of Molecular and Cellular Physiology, Stanford University School of Medicine, Stanford, CA, USA.
  • Department of Radiation Oncology, Stanford University, Stanford, CA, USA.
  • Department of Pediatrics, Stanford University, Stanford, CA, USA.
  • Department of Genetics, Stanford University, Stanford, CA, USA.
  • Department of Medicine, Division of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA.

ORCID-Profile: Grayson E Rodriguez, Yang Zhao, Frank Peprah, Jiao Shen, Gita C Abhiraman, Masato Ogishi, Chenyu Zhang, Justin Saco, Mamatha Serasanambati, Brandon W Simone, Leon Su, Steven C Wilson, Aerin Yang, Qinli Sun, Lora Picton, Robert A Saxton, Vidit Bhandarkar, Madeline J Lee, Elizabeth Andrews, Hua Jiang, Matthias Obenaus, Catherine A Blish, Stefani Spranger, E John Wherry, Amanda Kirane, Antoni Ribas, David H Raulet, Anusha Kalbasi, Stephanie K Dougan, Michael Dougan, Julien Sage, K Christopher Garcia

Förderung

  • NIGMS NIH HHS
  • NIAID NIH HHS
  • NCI NIH HHS
  • Howard Hughes Medical Institute
  • National Science Foundation
  • National Institutes of Health
  • Stanford University
  • University of California

Zitieren

APA

Rodriguez, G. E., Zhao, Y., Nishiga, Y., Peprah, F., Shen, J., Abhiraman, G. C., Ogishi, M., Zhang, C., Saco, J., Waghray, D., Serasanambati, M., Torres, L., Simone, B. W., Su, L., Wilson, S. C., Yang, A., Sun, Q., Picton, L., Saxton, R. A., …, & Garcia, K. C. (2026). Rewiring STAT signaling from the cell surface with Trikine immunotherapeutics. Science, 392(6799). https://doi.org/10.1126/science.adx9954

Vancouver

Rodriguez GE, Zhao Y, Nishiga Y, Peprah F, Shen J, Abhiraman GC, et al. Rewiring STAT signaling from the cell surface with Trikine immunotherapeutics. Science. 2026;392(6799). doi:10.1126/science.adx9954

BibTeX
@article{Rodriguez2026,
  author = {Rodriguez, Grayson E and Zhao, Yang and Nishiga, Yoko and Peprah, Frank and Shen, Jiao and Abhiraman, Gita C and Ogishi, Masato and Zhang, Chenyu and Saco, Justin and Waghray, Deepa and Serasanambati, Mamatha and Torres, Leonel and Simone, Brandon W and Su, Leon and Wilson, Steven C and Yang, Aerin and Sun, Qinli and Picton, Lora and Saxton, Robert A and Bhandarkar, Vidit and Lee, Madeline J and Andrews, Elizabeth and Jiang, Hua and Obenaus, Matthias and Yen, Michelle and Atajanova, Tavus and Blish, Catherine A and Spranger, Stefani and Wherry, E John and Kirane, Amanda and Ribas, Antoni and Raulet, David H and Kalbasi, Anusha and Dougan, Stephanie K and Dougan, Michael and Sage, Julien and Garcia, K Christopher},
  title = {Rewiring STAT signaling from the cell surface with Trikine immunotherapeutics},
  journal = {Science},
  year = {2026},
  volume = {392},
  number = {6799},
  doi = {10.1126/science.adx9954}
}
Kostenlos starten →